The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial.
about
Somatostatin analogues for pancreatic surgerySomatostatin analogues for pancreatic surgerySomatostatin analogues for pancreatic surgeryPerioperative management of distal pancreatectomySurgical quality data and survival after pancreatic cancer resections: a comparison of results for octogenarians and younger patients.Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane reviewPrediction of pancreatic fistula after pancreatoduodenectomy by preoperative dynamic CT and fecal elastase-1 levels.Drain amylase value as an early predictor of pancreatic fistula after cephalic duodenopancreatectomy.Techniques for prevention of pancreatic leak after pancreatectomy.Pancreatic surgery: evolution and current tailored approachProphylactic octreotide for pancreatoduodenectomy: more harm than good?Early enteral nutrition after pancreatoduodenectomy: a meta-analysis of randomized controlled trials.Moving towards the New International Study Group for Pancreatic Surgery (ISGPS) definitions in pancreaticoduodenectomy: a comparison between the old and new.Surgical treatment of pancreatic fistula.Current surgical management of pancreatic cancer.Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula.Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes.Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choiceImplications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience.Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management.Implications and cost of pancreatic leak following distal pancreatic resectionAnalysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery.Metaanalysis of trials comparing minimally invasive and open distal pancreatectomies.Dual-phase computed tomography for assessment of pancreatic fibrosis and anastomotic failure risk following pancreatoduodenectomy.Laparoscopic versus open distal pancreatectomy: a systematic review of comparative studies.Management of complications following pancreatic resection: an evidence-based approach.Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-reviewManagement of remnant pancreatic stump fto prevent the development of postoperative pancreatic fistulas after distal pancreatectomy: current evidence and our strategy.A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy.Predictive factors for pancreatic fistula following pancreatectomy.Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand?Attempts to prevent postoperative pancreatic fistula after distal pancreatectomy.Reconstruction by Pancreaticogastrostomy versus Pancreaticojejunostomy following Pancreaticoduodenectomy: A Meta-Analysis of Randomized Controlled Trials.Complications of pancreatic surgery.The case against preoperative biliary drainage with pancreatic resection.Anastomotic leakage in pancreatic surgerySingle-center experience of laparoscopic left pancreatic resection in 359 consecutive patients: changing the surgical paradigm of left pancreatic resection.Pancreatic cancer: progress made.
P2860
Q24197947-41985C62-A1A3-4C60-8261-040A2230C943Q24202647-0FCC74DA-1B2E-4BC7-8A0D-F49A11D1D3D5Q24239992-52E8A949-E46F-44EC-8F3D-91A2F76BD355Q28081524-F1898FA7-FA8F-4963-8E6D-112B96984AE6Q30854744-61C42A98-A537-4A00-B5F9-7C3AC5628986Q33621862-4A74490D-5435-4335-9944-9663E82DCE19Q33663964-34C62BC8-F0FA-4434-BFCC-C71D79A0C918Q33887142-BF5D221B-9734-456E-AEC1-80C0FE4B6D7FQ34395968-C94608ED-9362-41C1-BC9C-ED49F0B112F4Q34395976-B0A68BAE-5B30-43A0-82FA-00CFF37E07DBQ34548950-AFD9A0DA-1454-4CF8-903F-32523090217CQ34733210-D722A4E9-69D3-4D6C-8BED-C057D2AFE0A8Q35185205-D2AE530F-EAFB-4D4E-945C-7348932DF1AFQ35861971-86775CDD-3D90-47B8-9AEF-9641398CC340Q36097192-67EE159E-5E32-4A6D-BAC2-4D6F06844BD2Q36239183-F5F39014-86C7-45CB-94C1-27399FCF4D4BQ36786182-0B336510-9DB4-4C3A-B04E-4FEE2B0FEF9AQ36992760-B0670A5F-E24D-433A-8E0B-C26A45E75E93Q37195361-FBAFE98C-80D8-4941-81A9-2C3BFC51131DQ37231142-E36D40CC-0D0C-458C-B090-C58D1BC78AF0Q37249730-1D2F48BC-90D2-4924-888C-586639B0928FQ37294591-8BCCC2C8-4755-4AEE-857B-E962A63B19A9Q37721605-580D4445-AB9B-4167-AD12-E6C73D3907A0Q37806696-AE67E950-1094-46BA-9CF8-C2D4FEDFF4D0Q37823849-4A0D2900-1BF2-46DB-A7BE-FC79D476B8D7Q37938908-41E18FF2-6DD4-4363-BB7B-065F1C5AC13FQ37956153-C719C967-7289-4553-BA0F-F3151D5CCAC9Q38005643-48ECD297-8551-4196-B42C-331516036069Q38011708-0C152AFB-30BD-4095-A755-E961E228B679Q38055076-545FB914-3FA0-4CA6-B278-92D63BEF500AQ38198959-BBFF39C5-2F40-4ED1-9B2A-36C9F12B6012Q38222990-DBFD8701-4C19-441F-BB41-95482EB105D6Q38684607-1282A4CF-9DDE-4049-9221-B670C2008E59Q38871048-8DD533F4-DA9C-4FBB-8E58-02F472686BE1Q41981645-914CE6B9-89CB-450A-BC86-CB463764A8D9Q42015947-501AC668-7ABA-457E-834F-77AD70260E2CQ42571972-EF74CC75-6D60-4248-92D2-18DFDD2AD180Q42572009-27D33A4C-E9BC-45C5-8263-DFCEB9115ECDQ42600284-B3EA20D1-01B9-46F6-8104-B94E1FFE21CCQ43199289-19F4F6B4-9696-4668-9787-59DF3FBDAA1D
P2860
The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The potent somatostatin analog ...... zed, placebo-controlled trial.
@en
The potent somatostatin analog ...... zed, placebo-controlled trial.
@nl
type
label
The potent somatostatin analog ...... zed, placebo-controlled trial.
@en
The potent somatostatin analog ...... zed, placebo-controlled trial.
@nl
prefLabel
The potent somatostatin analog ...... zed, placebo-controlled trial.
@en
The potent somatostatin analog ...... zed, placebo-controlled trial.
@nl
P1476
The potent somatostatin analog ...... zed, placebo-controlled trial.
@en
P2093
Micheal G Sarr
Pancreatic Surgery Group
P304
556-64; discussion 564-5; author reply 565
P356
10.1016/S1072-7515(03)00104-2
P577
2003-04-01T00:00:00Z